Targeted Therapy : New Problems, New Exploration
WU Yi-long;SUN Yan;WANG Chang-li;LIAO Mei-lin;ZHOU Qing-hua;LU Shun;CHENG Ying;ZHOU Cai-cun;WANG Jie;ZHANG Li;CHEN Xiao-yuan;MAO Wei-min;JIANG Guo-liang;WANG Jun;WANG Qun;FENG Ji-feng;FU Xiao-long;YU Ding;HUANG Cheng;LIANG Jun;YU Shi-ying;MA Sheng-lin;YANG Jin-ji;XU Chong-rui;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:193-197

2015 nian zhong guo fei ai gao feng lun tan yu hui zhuan jia

..............page:197

An Interview at 2015 Chinese Lung Cancer Summit Forum
YU Lin;ZHANG Hua;Editorial Department of the Journal of Evidence-Based Medicine;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:198-205

Ten Years of A Sword
WU Yi-long;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:206-207

xun zheng yi xue za zhi kai tong scholarone manuscripts zai xian tou shen gao xi tong de tong zhi

..............page:207

Safety and Activity, AZD9291 and Rociletinib in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer
TU Hai-yan;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:208-209

Cumulative Incidence and Mortality of Esophageal Squamous Cell Carcinoma Declines due to One-Time Endoscopic Screening
WANG Meng;QIAO You-lin;Department of Epidemiology;Cancer Institute and Hospital;Chinese Academy of Medical Sciences;Peking Union Medical College;

..............page:210

The Present and Future of Lung Cancer Immune CheckPoint Treatment
JIANG Ben-yuan;WU Yi-long;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:211-212

Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
CHEN Xi;ZHOUJ ian-ying;LI Yang-si;Pneumology Department;The First Affiliated Hospital;Zhejiang University;

..............page:213-216

ben qi xun zheng ping jia yuan shi wen xian lai yuan qi kan

..............page:216

Association of PD-L1 Overexpression with Activating EGFR Mutations in Surgically Resected Non-Small Cell Lung Cancer
LIU Xiao-qing;HUANG Shu-mei;Department of Pulmonary Oncology;307 Hospital of PLA;

..............page:217-221

xun zheng yi xue za zhi zheng gao zheng ding tong zhi

..............page:221

The Correlation between Lung Cancer Mutation Spectrum and Immune Efficacy
ZHONG Wen-zha;ZHAI Hao-ran;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:222-224

Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small Cell Lung Cancer
LU Shun;YU Yong-feng;ZHANG Yi-chen;Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University;

..............page:225-227+231

Tumors with Mismatch-Repair Deficiency Improve the Clinical Efficacy of Anti-PD-1 Immunotherapy
XIONG Bin;DONG Zhong-yi;Department of Surgery;Zhongnan Hospital of Wuhan University;

..............page:228-231

Analysis of Serum Enzymes in Healthy Children and Adolescents by Dry Chemical System
LUO Xiao-juan;CAO Ke;MA Dong-li;LIU Xin-gang;HUANG Bao-xing;CHEN Yun-sheng;Department of Clinical Laboratory;Shenzhen Children’s Hospital;

..............page:232-236

Diagnostic Value Analysis of Serum NSE, CEA, CYFRA21-1 for Lung Cancer Based on ROC Curve and Logistic Regression
DI Yu-wei;YANG Xia;DUAN Wei;LIANG Min-wen;LI Zheng-kang;DONG Hui;Clinical Laboratory;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Pathology Department;Sun Yat-sen University Cancer Center;The First Hospital of Hebei Medical University;

..............page:237-241

Clinical Characteristics of Patients Hospitalized Again with Gastrointestinal Bleeding and Receiving Dual Antiplatelet Treatment after PCI
WANG Ling;LI Wei;LUO Jian-fang;LUO Song-yuan;CHEN Ji-yan;Department of Cardiology;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Provincial Cardiovascular Institute;

..............page:242-246+251

Introduction to Cumulative Meta-Analysis and Application of CMA Software
LI Guo-chun;The Center of Statistical Research and Consultation of TCM;Nanjing University of Chinese Medicine;

..............page:247-251

The Multimodality Therapy for Locally-Advanced Nasopharyngeal Carcinoma
YANG Li-hui;ZHENG Deng-yun;Division of Head and Neck Neoplasms;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;

..............page:252-256

xun zheng yi xue oa qi kan 2015 nian 1 yue 1 ri zheng shi shang xian

..............page:256